From the1Clinical Pharmacy Research Group (CLIP)–Louvain Drug Research Institute (LDRI), UCLouvain

2Fonds de la Recherche Scientifique—FNRS

3Institute of Neuroscience (IoNS), UCLouvain

4Psychiatry Department, Cliniques Universitaires Saint-Luc, Brussels

5Hôpital Psychiatrique du Beau Vallon, Namur

6Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics (PMGK)–Louvain Drug Research Institute (LDRI), UCLouvain

7Louvain Centre for Toxicology and Applied Pharmacology (LTAP)–Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain

8Pharmacy Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Received October 5, 2022; accepted after revision January 2, 2023.

Address correspondence to: Juliette Lagreula, MPharm, MSc, Clinical Pharmacy Research Group (CLIP)–Louvain Drug Research Institute (LDRI), Université Catholique de Louvain, Avenue Mounier 72, 1200 Brussels, Belgium (e-mail: [email protected]).

J.L. and M.F. equally contributed to this work.